US-based spinal device manufacturer ChoiceSpine has received the US Food and Drug Administration (FDA) approval to market its Triton Sacroiliac Joint Fixation System.
Triton SI Joint fixation is a 3D-Printed screw that facilitates sacroiliac joint fixation for conditions such as degenerative sacroiliitis as well as sacroiliac joint disruption.
The system includes open and porous graft openings for continuous porosity, and cannulated screws to allow for in-situ graft delivery to promote bone growth.
It also features a secure driver interface and internal threads for driver retention, along with a simple and easy-to-use instrumentation to simplify surgical steps in the operating room.
ChoiceSpine sales vice president Keith Clements said: “The addition of the Triton screw to our spinal fusion portfolio delivers on ChoiceSpine’s commitment to provide an innovative, superior system to the sacroiliac fixation market.
“By listening to our customer first and emphasising their positive end-user experience, it is just another example of how ChoiceSpine is doing spine the right way.”
ChoiceSpine said that the system features its unique BioBond, porous structure technology.
Also, its cannulated screw allows for in-situ graft delivery with open and porous graft windows designed to promote bone growth, said the medical devices company.
Triton is offered with three screw diameters, 8mm secondary, 12mm primary, and 14mm revision with lengths 30-65mm in 5mm increments.
Based in Knoxville, Tennessee, US, ChoiceSpine is engaged in providing various surgeon-focused product lines, designed to be safe, efficient, and easy to use.
Its other products include AMBASSADOR Anterior Cervical Plate System, VEO PEEK Lateral Interbody Spacer System and TIGERSHARK Spinal Stabilisation System.
The company also offers THUNDERBOLT Minimally Invasive Pedicle Screw System, BLACKHAWK Self-Locking Integrated Cervical Spacer System and BLACKHAWK Self-Locking Integrated Cervical Spacer System.
ChoiceSpine is privately held by Altus Capital Partners, a private equity firm that makes investments in middle-market manufacturing businesses.
